The U.S.
Link:
FDA Expands Use of CSL Limited’s Seasonal and H1N1 Vaccines to Infants and Children
The U.S. Food and Drug Administration has approved the use of the CSL Limited’s 2009 H1N1 influenza vaccine to include children ages 6 months and older.
More:
FDA Expands Approved Use of H1N1 Vaccines to Include Infants and Children